Autopsy report · NCT05352763
Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease
Cause of deathFunding or business
“Sponsor Decision”
Life of this trial
- Registered 1 month before it started.
- Ran for about 2 years 8 months before it stopped.
- 90 participants enrolled.
- Results were posted on the registry 7 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Cassava Sciences, Inc.
- Sponsor type
- Industry
- Conditions
- Alzheimer's Disease
- Interventions
- simufilam
- Participants
- 90
- Sites
- 11
- Countries
- Canada, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.